* Active liver disease: cholestasis, hepatic encephalopathy, hepatitis, and jaundice * Unexplained elevations in AST or ALT levels * Pregnancy:<unk>  may cause fetal harm by affecting serum cholesterol and triglyceride levels, which are essential for fetal development. * Breastfeeding: Small amounts of other statin medications have been found to pass into breast milk, although<unk>  has not been studied, specifically. Due to risk of disrupting a breastfeeding infant's metabolism of lipids,<unk>  is not regarded as compatible with breastfeeding. * Markedly elevated CPK levels or if a myopathy is suspected or diagnosed after dosing of<unk>  has begun. Very rarely,<unk>  may cause rhabdomyolysis, and it may be very serious leading to acute kidney injury due to myoglobinuria. If rhabdomyolysis is suspected or diagnosed,<unk>  therapy should be discontinued immediately. The likelihood of developing a myopathy is increased by the co-administration of cyclosporine, fibric acid derivatives, erythromycin, niacin, and azole antifungals.
Atorvastatin
Clofibrate
Simvastatin
Fenofibrate
Lovastatin
Ezetimibe
Fluvastatin
Pravastatin